If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTCM.L Regulatory News (TCM)

  • There is currently no data for TCM

Director's Dealing

3 Jul 2017 14:47

RNS Number : 9593J
Telit Communications PLC
03 July 2017
 

3 July 2017

 

Telit Communications PLC

 

Director's Dealing

 

Telit Communications PLC ("Telit", "the Company", AIM: TCM), announces that Mr. Oozi Cats, the Company's Chief Executive, exercised 1,952,000 options over ordinary shares of the Company and retained the resulting 1,447,656 shares. The exercise price of the options, which were granted in 2011, was 81p and they were exercised in a cashless manner, based on the closing price of the shares on the date Mr. Cats provided the Company with the exercise notice (29 June 2017). In addition, Mr. Cats acquired 75,215 shares on 29 June 2017, at a price of 312.39 pence per share. See further details in the form below.

 

Following the transaction, Mr. Cats holds 16,333,470 shares, representing 12.6% of the issued share capital of the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Oozi Cats

2.

Reason for the notification

a)

Position / status

Chief Executive; director

 

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Telit Communications PLC

b)

Legal Entity Identifier

n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Options over ordinary shares

b)

Nature of the transaction

Cashless exercise of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price: 81 pence

1,952,000 options

 

The options were exercised on a cashless basis. Actual number of resulting shares, which were retained by Mr. Cats, was 1,447,656.

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

N/A - single transaction

e)

Date of the transaction

3 July 2017 (UK)

f)

Place of the transaction

Outside a trading venue

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 1 pence each ("Ordinary Shares")

 

ISIN number GB00B06GM726

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

312.39 pence

75,215

 

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

 

N/A - single transaction

e)

Date of the transaction

29 June 2017(UK)

f)

Place of the transaction

London Stock Exchange, AIM

 

 

For further information:

 

Telit Communications PLC

Tel: +39 06 4204601

Yosi Fait, Finance Director & President

 

Canaccord Genuity Limited (Nominated Adviser)

Tel: +44 20 7523 8000

Simon Bridges/ Martin Davison

 

Instinctif Partners

Tel: +44 20 7457 2020

Adrian Duffield/Chantal Woolcock

 

Berenberg (Joint Broker)

Tel: +44 20 3465 2722

Chris Bowman/Ben Wright

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUGUQCMUPMGWW
Date   Source Headline
9th Aug 20191:35 pmRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSBlock listing return
18th Jul 201910:43 amRNSHolding(s) in Company
17th Jul 20197:00 amRNSHalf year trading update
2nd Jul 20192:00 pmRNSChange of Adviser
2nd Jul 20198:00 amRNSGrant of Options
1st Jul 20192:00 pmRNSDirectorate Changes
1st Jul 20197:30 amRNSResponse to AIM censure
24th Jun 20198:17 amRNSHolding(s) in Company
21st Jun 20196:27 pmRNSHolding(s) in Company
6th Jun 201912:25 pmRNSResult of AGM
29th May 20192:31 pmRNSHolding(s) in Company
22nd May 20197:00 amRNSPaolo Dal Pino appointed Chief Executive Officer
15th May 20193:54 pmRNSHolding(s) in Company
13th May 20197:00 amRNSNotice of AGM
8th May 20193:32 pmRNSHolding(s) in Company
8th May 201910:58 amRNSHolding(s) in Company
8th May 20197:00 amRNSUpdate on Italian VAT Assessment
7th May 20194:23 pmRNSHolding(s) in Company
3rd May 20199:46 amRNSHolding(s) in Company
2nd May 20197:00 amRNSDirector/PDMR Shareholding
26th Apr 20191:47 pmRNSHolding(s) in Company
18th Apr 20198:19 amRNSHolding(s) in Company
16th Apr 20197:00 amRNSYear end results
15th Apr 201910:22 amRNSVendor Loan repaid
11th Apr 20197:00 amRNSHolding(s) in Company
1st Apr 20197:00 amRNSTotal Voting Rights
19th Mar 20194:05 pmRNSBAMES settlement agreement
13th Mar 20192:39 pmRNSNotice of Results
27th Feb 201911:37 amRNSAutomotive division sale completed
21st Feb 20192:34 pmRNSUpdate on Automotive deal
20th Feb 20193:10 pmRNSUpdate: Automotive deal
1st Feb 20199:00 amRNSBlock Listing Return
1st Feb 20197:00 amRNSUpdate on sale of automotive division
16th Jan 20192:48 pmRNSDirector/PDMR Shareholding
15th Jan 20197:00 amRNSYear end trading update
27th Dec 20187:00 amRNSUpdate on sale of automotive division
18th Dec 20187:00 amRNSFCA investigation
11th Dec 20187:00 amRNSUpdate:sale of automotive, trading & 2019 outlook
6th Nov 201810:04 amRNSHolding(s) in Company
6th Nov 20188:58 amRNSHolding(s) in Company
5th Nov 20183:46 pmRNSHolding(s) in Company
1st Nov 20187:00 amRNSTotal Voting Rights
31st Oct 20181:29 pmRNSHolding(s) in Company
26th Oct 20187:00 amRNSHolding(s) in Company
24th Oct 20187:00 amRNSDirector/PDMR Shareholding
18th Oct 20189:36 amRNSDirector/PDMR Shareholding
17th Oct 20185:57 pmRNSHolding(s) in Company
17th Oct 20182:42 pmRNSHolding(s) in Company
17th Oct 201810:44 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.